The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Guideline on the prevention and control of seasonal influenza in healthcare setting

  • Baek, Ji Hyeon (Department of Internal Medicine, Inha University School of Medicine) ;
  • Seo, Yu Bin (Department of Internal Medicine, Hallym University College of Medicine) ;
  • Choi, Won Suk (Department of Internal Medicine, Korea University College of Medicine) ;
  • Kee, Sae Yoon (Department of Internal Medicine, Konkuk University School of Medicine) ;
  • Jeong, Hye Won (Department of Internal Medicine, Chungbuk National University College of Medicine) ;
  • Lee, Hee Young (Gachon University Gil Hospital Cancer Center, Gachon University Gil Medical Center) ;
  • Eun, Byung Wook (Department of Pediatrics, Eulji University School of Medicine) ;
  • Choo, Eun Ju (Department of Internal Medicine, Soonchunhyang University College of Medicine) ;
  • Lee, Jacob (Department of Internal Medicine, Hallym University College of Medicine) ;
  • Kim, Sung Ran (Infection Control Unit, Korea University Guro Hospital) ;
  • Kim, Young Keun (Department of Internal Medicine, Yonsei University Wonju College of Medicine) ;
  • Song, Joon Young (Department of Internal Medicine, Inha University School of Medicine) ;
  • Wie, Seong-Heon (Department of Internal Medicine, The Catholic University of Korea College of Medicine) ;
  • Lee, Jin-Soo (Department of Internal Medicine, Inha University School of Medicine) ;
  • Cheong, Hee Jin (Department of Internal Medicine, Korea University College of Medicine) ;
  • Kim, Woo Joo (Department of Internal Medicine, Korea University College of Medicine) ;
  • Transgovernmental Enterprise for Pandemic Influenza in Korea (Transgovernmental Enterprise for Pandemic Influenza in Korea)
  • Received : 2014.02.15
  • Accepted : 2014.02.20
  • Published : 2014.03.01
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Choi WS, Lee J, Lee HY, et al. Clinical practice guideline for antiviral treatment and chemoprophylaxis of seasonal influenza. Infect Chemother 2012;44:233-249. https://doi.org/10.3947/ic.2012.44.4.233
  2. Korea Centers for Disease Control and Prevention. Weekly sentinel surveillance report [Internet]. Cheongwon (Kr): Korean Centers for Disease Control and Prevention, c2013 [cited 2013 Dec 28]. Available from: http://www.cdc.go.kr/ CDC/info/CdcKrInfo0402.jsp?menuIds=HOME001- MNU1132-MNU1138-MNU0045.
  3. Fiore AE, Fry A, Shay D, et al. Antiviral agents for the treatment and chemoprophylaxis of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011;60:1-24.
  4. Committee on Infectious Diseases, American Academy of Pediatrics. Recommendations for prevention and control of inf luenza in children, 2012-2013. Pediatrics 2012;130:780-792. https://doi.org/10.1542/peds.2012-2308
  5. Harper SA, Bradley JS, Englund JA, et al. Seasonal inf luenza in adults and children: diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009;48:1003-1032. https://doi.org/10.1086/598513
  6. National Institute for Health and Clinical Excellence. Amantadine, oseltamivir and zanamivir for the treatment of inf luenza [Internet]. London (UK): National Institute for Health and Clinical Excellence, c2013 [cited 2013 Dec 28]. Available from: http://publications. nice.org.uk/amantadine-oseltamivir-and-zanamivir-for-the-treatment-of-influenza-ta168.
  7. Mandell GL, Bennett JE, Dolin R. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Elsevier Health Sciences, 2009.
  8. National Evidence-Based Healthcare Collaboratory Agency. Evaluation of the Effectiveness of the Seasonal Flu Vaccine and the Disease Burden of Seasonal Flu in Korea. Seoul: National Evidence-Based Healthcare Collaboratory Agency, 2010.
  9. Weingarten S, Friedlander M, Rascon D, Ault M, Morgan M, Meyer RD. Inf luenza surveillance in an acutecare hospital. Arch Intern Med 1988;148:113-116. https://doi.org/10.1001/archinte.1988.00380010117011
  10. Adal KA, Flowers RH, Anglim AM, et al. Prevention of nosocomial influenza. Infect Control Hosp Epidemiol 1996;17:641-648. https://doi.org/10.2307/30141297
  11. Weinstock DM, Eagan J, Malak SA, et al. Control of inf luenza A on a bone marrow transplant unit. Infect Control Hosp Epidemiol 2000;21:730-732. https://doi.org/10.1086/501726
  12. Kapila R, Lintz DI, Tecson FT, Ziskin L, Louria DB. A nosocomial outbreak of influenza A. Chest 1977;71:576-579. https://doi.org/10.1378/chest.71.5.576
  13. Van Voris LP, Belshe RB, Shaffer JL. Nosocomial influenza B virus infection in the elderly. Ann Intern Med 1982;96:153-158. https://doi.org/10.7326/0003-4819-96-2-153
  14. Malavaud S, Malavaud B, Sandres K, et al. Nosocomial outbreak of inf luenza virus A (H3N2) infection in a solid organ transplant department. Transplantation 2001;72:535-537. https://doi.org/10.1097/00007890-200108150-00032
  15. Gowda HT. Influenza in a geriatric unit. Postgrad Med J 1979;55:188-191. https://doi.org/10.1136/pgmj.55.641.188
  16. Munoz FM, Campbell JR, Atmar RL, et al. Influenza A virus outbreak in a neonatal intensive care unit. Pediatr Infect Dis J 1999;18:811-815. https://doi.org/10.1097/00006454-199909000-00013
  17. Gravenstein S, Miller BA, Drinka P. Prevention and control of influenza A outbreaks in long-term care facilities. Infect Control Hosp Epidemiol 1992;13:49-54. https://doi.org/10.2307/30146967
  18. Salgado CD, Farr BM, Hall KK, Hayden FG. Inf luenza in the acute hospital setting. Lancet Infect Dis 2002;2:145-155. https://doi.org/10.1016/S1473-3099(02)00221-9
  19. Sagrera X, Ginovart G, Raspall F, et al. Outbreaks of inf luenza A virus infection in neonatal intensive care units. Pediatr Infect Dis J 2002;21:196-200. https://doi.org/10.1097/00006454-200203000-00007
  20. Mejia C, Silvestre M, Cazali I, et al. Large epidemiological inf luenza a outbreak in a teaching hospital from guatemala city. ISRN AIDS 2012;2012:638042.
  21. Bean B, Moore BM, Sterner B, Peterson LR, Gerding DN, Balfour HH Jr. Survival of influenza viruses on environmental surfaces. J Infect Dis 1982;146:47-51. https://doi.org/10.1093/infdis/146.1.47
  22. Carrat F, Vergu E, Ferguson NM, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008;167:775-785. https://doi.org/10.1093/aje/kwm375
  23. Hall CB, Douglas RG Jr. Nosocomial inf luenza infection as a cause of intercurrent fevers in infants. Pediatrics 1975;55:673-677.
  24. Lee N, Chan PK, Hui DS, et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis 2009;200:492-500. https://doi.org/10.1086/600383
  25. McNeil S, Krajden O, Gajic S, et al. Performance characteristics of inf luenza-like-illness case definitions in predicting inf luenza in hospitalized Canadian adults. Poster presented at: ID Week 2012, Advancing Science, Improving Care; 2012 Oct 20; San Diego, CA. Poster No. 1496.
  26. Uyeki TM. Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for inf luenza. Pediatr Infect Dis J 2003;22:164-177.
  27. Schmid ML, Kudesia G, Wake S, Read RC. Prospective comparative study of culture specimens and methods in diagnosing influenza in adults. BMJ 1998;316:275. https://doi.org/10.1136/bmj.316.7127.275
  28. Sung RY, Chan PK, Choi KC, et al. Comparative study of nasopharyngeal aspirate and nasal swab specimens for diagnosis of acute viral respiratory infection. J Clin Microbiol 2008;46:3073-3076. https://doi.org/10.1128/JCM.01209-08
  29. Storch GA. Rapid diagnostic tests for inf luenza. Curr Opin Pediatr 2003;15:77-84. https://doi.org/10.1097/00008480-200302000-00013
  30. Grijalva CG, Poehling KA, Edwards KM, et al. Accuracy and interpretation of rapid influenza tests in children. Pediatrics 2007;119:e6-e11. https://doi.org/10.1542/peds.2006-1694
  31. Uyeki TM, Prasad R, Vukotich C, et al. Low sensitivity of rapid diagnostic test for inf luenza. Clin Infect Dis 2009;48:e89-e92. https://doi.org/10.1086/597828
  32. Nichol KL, Lind A, Margolis KL, et al. The effectiveness of vaccination against inf luenza in healthy, working adults. N Engl J Med 1995;333:889-893. https://doi.org/10.1056/NEJM199510053331401
  33. Salgado CD, Giannetta ET, Hayden FG, Farr BM. Preventing nosocomial influenza by improving the vaccine acceptance rate of clinicians. Infect Control Hosp Epidemiol 2004;25:923-928. https://doi.org/10.1086/502321
  34. Carman WF, Elder AG, Wallace LA, et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet 2000;355:93-97. https://doi.org/10.1016/S0140-6736(99)05190-9
  35. Potter J, Stott DJ, Roberts MA, et al. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis 1997;175:1-6.
  36. Choi S, Kim SM, Kim ES, Lee JS, Cheong MH. The adverse reactions of influenza vaccination in the healthcare workers in a university hospital. Infect Chemother 2004;36:319-320.
  37. Song JY, Park CW, Jeong HW, Cheong HJ, Kim WJ, Kim SR. Effect of a hospital campaign for influenza vaccination of healthcare workers. Infect Control Hosp Epidemiol 2006;27:612-617. https://doi.org/10.1086/504503
  38. Center for Disease Control and Prevention. Prevention strategies for seasonal influenza in healthcare settings [Internet]. Atlanta (GA): Center for Disease Control and Prevention, 2013 [cited 2014 Jan 28]. Available from: http://www.cdc.gov/flu/professionals/infectioncontrol/healthcaresettings.htm.
  39. Kramer A, Schwebke I, Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 2006;6:130. https://doi.org/10.1186/1471-2334-6-130
  40. U.S. Environmental Protection Agency. Guidance for testing and labeling claims against pandemic 2009 H1N1 influenza A virus [Internet]. Washington, DC: U.S. Environmental Protection Agency, 2012 [cited 2014 Jan 28]. Available from: http://www.epa.gov/oppad001/h1n1-guide.html.

Cited by

  1. Influenza Vaccination and Associated Factors among Korean Cancer Survivors : A Cross-Sectional Analysis of the Fourth & Fifth Korea National Health and Nutrition Examination Surveys vol.29, pp.8, 2014, https://doi.org/10.3346/jkms.2014.29.8.1061
  2. Knowledge, attitudes, and acceptability about influenza vaccination in Korean women of childbearing age vol.58, pp.2, 2014, https://doi.org/10.5468/ogs.2015.58.2.81
  3. 간호사의 인플루엔자 감염관리 이행에 영향을 미치는 요인 vol.23, pp.2, 2014, https://doi.org/10.7739/jkafn.2016.23.2.161
  4. Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea vol.33, pp.2, 2014, https://doi.org/10.3904/kjim.2018.036
  5. The coverage rates for influenza vaccination and related factors in Korean adults aged 50 and older with chronic disease: based on 2016 Community Health Survey data vol.40, pp.None, 2014, https://doi.org/10.4178/epih.e2018034
  6. 우리나라 성인 당뇨병 환자에서 인플루엔자 예방접종 관련요인 vol.19, pp.6, 2018, https://doi.org/10.5762/kais.2018.19.6.447
  7. 상급종합병원 임상실습 학생의 메르스 예방행위 수행 예측요인 vol.19, pp.9, 2014, https://doi.org/10.5762/kais.2018.19.9.174
  8. 50세 이상 천식 환자의 인플루엔자 백신 접종률 및 관련 요인 vol.19, pp.3, 2014, https://doi.org/10.35133/kssche.20181231.02
  9. Age-Period-Cohort Analysis of Influenza in Koreans: the National Health Insurance Research Database, 2009–2018 vol.35, pp.18, 2014, https://doi.org/10.3346/jkms.2020.35.e121
  10. The Correlation of Comorbidities on the Mortality in Patients with COVID-19: an Observational Study Based on the Korean National Health Insurance Big Data vol.35, pp.26, 2014, https://doi.org/10.3346/jkms.2020.35.e243
  11. COVID‐19: Comparing the applicability of shared room and single room occupancy vol.68, pp.4, 2014, https://doi.org/10.1111/tbed.13853
  12. Influenza Vaccination Status and Its Affecting Factors among Stroke Survivors: Findings from the Korea National Health and Nutrition Examination Survey vol.9, pp.7, 2014, https://doi.org/10.3390/vaccines9070763